DALY JASON B. (SVP, Chief Legal Officer) sold 86.0% of their position (216.61K shares) of AMNEAL PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $3.77M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/13/2026ACC: 0001628280-26-056754
Officer· SVP, Chief Legal Officer
Since Jan 2022
-216.61K
Net shares
Net seller
$3.77M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
216.61K disposed
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
−6.61K
Price / share
$17.70
Trade value
$117.05K
% of position
2.6%
8/11/2026
251.78K→245.17K
Class A Common Stock
Direct
Shares
−210K
Price / share
$17.40
Trade value
$3.65M
% of position
85.7%
8/12/2026
245.17K→35.17K
Total
Net shares
−216.61K
Net value
-$3.77M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 8/11/2026 | S · Sale | −6.61K | $17.70 | $117.05K | 2.6% | 251.78K | 245.17K |
| Class A Common Stock Direct | 8/12/2026 | S · Sale | −210K | $17.40 | $3.65M | 85.7% | 245.17K | 35.17K |
| Total | −216.61K | -$3.77M | ||||||
Derivative Transactions0
No derivative transactions reported